131 related articles for article (PubMed ID: 35168438)
1. A look towards the clonal origin of metastatic pulmonary carcinosarcoma: Report of a patient with an unexpected long-term survival.
Spagnoli L; Petrelli F; Fratini G; De Nisi MC; Camerini A; Giusti A; Perotti B; Cavazzana A; Arganini M; Ambrosio MR
Tumori; 2022 Dec; 108(6):NP5-NP10. PubMed ID: 35168438
[TBL] [Abstract][Full Text] [Related]
2. Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung.
Vieira T; Antoine M; Ruppert AM; Fallet V; Duruisseaux M; Giroux Leprieur E; Poulot V; Rabbe N; Sclick L; Beau-Faller M; Lacave R; Lavole A; Cadranel J; Wislez M
Lung Cancer; 2014 Aug; 85(2):276-81. PubMed ID: 24997135
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Lung Carcinosarcoma and Other Rare Histologic Subtypes of Non-small Cell Lung Cancer.
Yang H; Lin Y; Liang Y
Curr Treat Options Oncol; 2017 Aug; 18(9):54. PubMed ID: 28795312
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of
Yu Y; Zhang Q; Zhang J; Lu S
J Cancer Res Ther; 2019; 15(4):909-913. PubMed ID: 31436251
[TBL] [Abstract][Full Text] [Related]
5. Inter-relationship between PD-L1 expression and clinic-pathological features and driver gene mutations in pulmonary sarcomatoid carcinomas.
Lococo F; Torricelli F; Rossi G; Alifano M; Damotte D; Rapicetta C; Tamagnini I; Cavazza A; Piana S; Galeone C; Paci M; Ciarrocchi A
Lung Cancer; 2017 Nov; 113():93-101. PubMed ID: 29110857
[TBL] [Abstract][Full Text] [Related]
6. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.
Matsuzaki S; Klar M; Matsuzaki S; Roman LD; Sood AK; Matsuo K
Gynecol Oncol; 2021 Feb; 160(2):586-601. PubMed ID: 33183764
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer.
Pelosi G; Gasparini P; Conte D; Fabbri A; Perrone F; Tamborini E; Pupa SM; Ciravolo V; Caserini R; Rossi G; Cavazza A; Papotti M; Nakatani Y; Maisonneuve P; Pastorino U; Sozzi G
J Thorac Oncol; 2016 May; 11(5):718-728. PubMed ID: 26804638
[TBL] [Abstract][Full Text] [Related]
8. High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.
Fallet V; Saffroy R; Girard N; Mazieres J; Lantuejoul S; Vieira T; Rouquette I; Thivolet-Bejui F; Ung M; Poulot V; Schlick L; Moro-Sibilot D; Antoine M; Cadranel J; Lemoine A; Wislez M
Ann Oncol; 2015 Aug; 26(8):1748-53. PubMed ID: 25969368
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous carcinosarcoma: insights into its clonal origin and mutational pattern expression analysis through next-generation sequencing.
Paniz Mondolfi AE; Jour G; Johnson M; Reidy J; Cason RC; Barkoh BA; Benaim G; Singh R; Luthra R
Hum Pathol; 2013 Dec; 44(12):2853-60. PubMed ID: 24071013
[TBL] [Abstract][Full Text] [Related]
10. Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer.
Assoun S; Theou-Anton N; Nguenang M; Cazes A; Danel C; Abbar B; Pluvy J; Gounant V; Khalil A; Namour C; Brosseau S; Zalcman G
Lung Cancer; 2019 Jun; 132():65-71. PubMed ID: 31097096
[TBL] [Abstract][Full Text] [Related]
11. A clinical analysis of 114 cases of sarcomatoid carcinoma of the lung.
Hou J; Xing L; Yuan Y
Clin Exp Med; 2018 Nov; 18(4):555-562. PubMed ID: 29987681
[TBL] [Abstract][Full Text] [Related]
12. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing.
Paniz-Mondolfi A; Singh R; Jour G; Mahmoodi M; Diwan AH; Barkoh BA; Cason R; Huttenbach Y; Benaim G; Galbincea J; Luthra R
Virchows Arch; 2014 Sep; 465(3):339-50. PubMed ID: 25031014
[TBL] [Abstract][Full Text] [Related]
14. Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma.
Lococo F; Gandolfi G; Rossi G; Pinto C; Rapicetta C; Cavazza A; Cesario A; Galeone C; Paci M; Ciarrocchi A
J Thorac Oncol; 2016 Aug; 11(8):1282-1292. PubMed ID: 27156442
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of six patients with pulmonary carcinosarcoma with a literature review.
Sökücü SN; Kocatürk C; Urer N; Sönmezoğlu Y; Dalar L; Karasulu L; Altın S; Bedirhan MA
ScientificWorldJournal; 2012; 2012():167317. PubMed ID: 22619609
[TBL] [Abstract][Full Text] [Related]
16. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
Schrock AB; Li SD; Frampton GM; Suh J; Braun E; Mehra R; Buck SC; Bufill JA; Peled N; Karim NA; Hsieh KC; Doria M; Knost J; Chen R; Ou SI; Ross JS; Stephens PJ; Fishkin P; Miller VA; Ali SM; Halmos B; Liu JJ
J Thorac Oncol; 2017 Jun; 12(6):932-942. PubMed ID: 28315738
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Programmed Death Receptor-Ligand 1 Expression and Response to Checkpoint Inhibitor Immunotherapy in Pulmonary Sarcomatoid Carcinoma: A Pooled Analysis.
Babacan NA; Pina IB; Signorelli D; Prelaj A; Garassino MC; Tanvetyanon T
Clin Lung Cancer; 2020 Sep; 21(5):e456-e463. PubMed ID: 32265109
[TBL] [Abstract][Full Text] [Related]
19. Maxillary carcinosarcoma: Identification of a novel MET mutation in both carcinomatous and sarcomatous components through next generation sequencing.
Ando M; Saito Y; Morikawa T; Omura G; Kobayashi K; Akashi K; Yoshida M; Ebihara Y; Fujimoto C; Fukayama M; Yamasoba T; Asakage T
Head Neck; 2015 Dec; 37(12):E179-85. PubMed ID: 25782598
[TBL] [Abstract][Full Text] [Related]
20. [Current Status of Diagnosis and Treatment of Pulmonary Sarcomatoid Carcinoma].
Liu L; Zang R; Song P; Gao S
Zhongguo Fei Ai Za Zhi; 2018 Dec; 21(12):902-906. PubMed ID: 30591097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
